Why in News
🗞️ Why in News
In July 2026 (effective on or around July 10), the Union Ministry of Health and Family Welfare ended the long-standing licensing exemption for medicinal formulations containing more than 12 per cent ethyl alcohol. Such formulations now require a licence under the Drugs and Cosmetics Act, 1940, and can be sold only against a prescription. The move is aimed at curbing the misuse of certain medicinal syrups and tinctures as cheap intoxicants.
What Has Changed
For decades, a category of medicinal preparations with a high alcohol content, including several traditional and Ayurvedic tinctures and certain syrups, could be manufactured and sold without a drug licence because they fell within an exemption. That exemption is now withdrawn for any formulation carrying more than 12 per cent ethyl alcohol by content.
The consequence is twofold. First, a manufacturer of such a formulation must now hold a manufacturing licence and comply with the quality and labelling discipline of the drug law. Second, the product moves behind the pharmacy counter: it can be dispensed only on a registered medical practitioner’s prescription, and its sale must be recorded.
The public-health logic is direct. In several states, low-cost, freely available high-alcohol “medicines” had become a substitute for liquor, especially where alcohol is prohibited or heavily taxed. Sold without a prescription and without a sales record, they were consumed as intoxicants rather than as medicine. Bringing them under licensing converts an unregulated retail product into a controlled pharmaceutical.
The Governing Framework
The Statute and the Rules
The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945 together regulate the import, manufacture, distribution and sale of drugs and cosmetics in India. The Act is the parent legislation; the Rules carry the operational detail, including the schedules that classify drugs by the degree of control they need.
The Regulator
The Central Drugs Standard Control Organisation (CDSCO), under the Health Ministry, is the national drug regulator. It is headed by the Drugs Controller General of India (DCGI). CDSCO sets standards, approves new drugs and clinical trials, and coordinates the regulatory system, while State Drug Controllers handle much of the on-ground licensing and enforcement.
The Schedules
The Rules place drugs into schedules according to how tightly their sale must be controlled.
| Category | What it means |
|---|---|
| Schedule H | Prescription-only drugs |
| Schedule H1 | Drugs requiring a prescription and a maintained sale record (includes certain antibiotics and habit-forming drugs) |
| Schedule X | Narcotic and psychotropic drugs needing the strictest controls |
| Prior exemption | Allowed certain high-alcohol traditional and other preparations to be sold without a drug licence |
The July 2026 decision effectively pulls high-alcohol formulations out of that last row and into the discipline of the prescription regime.
Why It Is a Governance Question
The measure sits at the intersection of public health, federalism and enforcement capacity, which is what makes it a GS2 issue rather than a purely medical one.
Health is a State subject, drug standards are shared. Drug manufacturing licences are issued by State licensing authorities, so a rule tightened at the Centre only bites when States enforce it uniformly. A formulation blocked in one State can still be manufactured across a border and trafficked back, which is precisely how the misuse spread in the first place.
Access versus control. Some of the affected tinctures have genuine therapeutic use. A prescription requirement must not put legitimate medicine out of reach of poorer patients even as it shuts the door on misuse. Calibrating that balance, rather than a blanket ban, is the harder policy craft.
Enforcement is the binding constraint. India’s drug inspectorate is thinly staffed relative to the scale of the retail pharmacy sector. A rule is only as strong as the inspection and prosecution that back it, and here the record has historically been weak.
Way Forward
The reform is sound in principle: an intoxicant masquerading as medicine should not enjoy an exemption designed for genuine remedies. Its success now depends on Centre-State coordination so that licensing is applied consistently across borders, on strengthening the drug inspectorate so that the prescription requirement is actually policed, and on protecting legitimate access for patients who need these formulations. Regulation on paper closes the loophole; only enforcement closes the trade.
UPSC Relevance
GS Paper 2: Government policies and interventions for development in the health sector, issues relating to the regulation of substance misuse, Centre-State coordination in a federal subject, and the role of regulatory bodies.
Prelims pointers:
- The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945 regulate the import, manufacture, distribution and sale of drugs and cosmetics in India.
- The CDSCO is the national drug regulator, headed by the Drugs Controller General of India (DCGI).
- Schedule H1 lists drugs that require a prescription and a maintained sales record.
- Drug manufacturing licences are issued by State licensing authorities, making this a shared Centre-State function.
- The 2026 measure applies to formulations with more than 12 per cent ethyl alcohol, ending their earlier licensing exemption.
Mains question: “The withdrawal of the licensing exemption for high-alcohol medicinal formulations shows how a public-health objective depends on federal coordination and enforcement capacity. Discuss the challenges of regulating substance misuse in India while safeguarding legitimate access to medicines.” (15 marks, 250 words)
Facts Corner
📌 Facts Corner, Knowledgepedia
- Measure: July 2026, the Health Ministry ended the licensing exemption for medicinal formulations with more than 12 per cent ethyl alcohol; now licensed and prescription-only.
- Aim: curb misuse of high-alcohol syrups and tinctures as intoxicants.
- Statute: Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 regulate import, manufacture, distribution and sale of drugs and cosmetics.
- Regulator: CDSCO, headed by the DCGI, is the national drug regulator.
- Schedule H1: prescription plus a maintained sales record.
- Federalism: manufacturing licences are issued by State licensing authorities.
Sources: Ministry of Health and Family Welfare, Central Drugs Standard Control Organisation, The Hindu
Source: Health Ministry Ends Licensing Exemption for High-Alcohol Medicines — Ujiyari.com | Free UPSC & State PCS Current Affairs
